• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial.

作者信息

Hoffbrand A V, Bartlett A N, Veys P A, O'Connor N T, Kontoghiorghes G J

出版信息

Lancet. 1989 Aug 19;2(8660):457. doi: 10.1016/s0140-6736(89)90641-7.

DOI:10.1016/s0140-6736(89)90641-7
PMID:2569644
Abstract
摘要

相似文献

1
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial.
Lancet. 1989 Aug 19;2(8660):457. doi: 10.1016/s0140-6736(89)90641-7.
2
Agranulocytosis and thrombocytopenia, Blackfan-Diamond anaemia, and oral chelation.
Lancet. 1990 Apr 21;335(8695):970. doi: 10.1016/0140-6736(90)91031-5.
3
Deferiprone-associated myelotoxicity.去铁酮相关的骨髓毒性。
Eur J Haematol. 1994 Nov;53(5):298-301. doi: 10.1111/j.1600-0609.1994.tb01323.x.
4
Development of oral iron chelator L1.
Lancet. 1993 Apr 24;341(8852):1088-9. doi: 10.1016/0140-6736(93)92444-x.
5
Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examination.去铁酮所致粒细胞缺乏症：一例伴有骨髓细胞形态学和功能检查的病例报告
Blood Transfus. 2011 Oct;9(4):462-5. doi: 10.2450/2011.0098-10. Epub 2011 Jul 18.
6
Agranulocytosis with deferiprone treatment of superficial siderosis.去铁酮治疗浅表性铁沉积症并发粒细胞缺乏症
BMJ Case Rep. 2013 Aug 7;2013:bcr2013010099. doi: 10.1136/bcr-2013-010099.
7
Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia.口服铁螯合剂去铁酮在中国依赖输血的地中海贫血儿童中的安全性概况
Curr Drug Saf. 2016;11(2):137-44. doi: 10.2174/1574886310666150930113957.
8
A multi-center safety trial of the oral iron chelator deferiprone.口服铁螯合剂去铁酮的多中心安全性试验。
Ann N Y Acad Sci. 1998 Jun 30;850:223-6. doi: 10.1111/j.1749-6632.1998.tb10478.x.
9
Deferiprone in iron overload.
N Engl J Med. 1995 Aug 31;333(9):598-9.
10
Necrotizing stomatitis: a possible periodontal manifestation of deferiprone-induced agranulocytosis.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Oct;108(4):e13-9. doi: 10.1016/j.tripleo.2009.06.021.

引用本文的文献

1
Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data.地拉罗司治疗患者的严重中性粒细胞减少症和感染风险率：28 年的数据。
Blood Adv. 2024 Nov 12;8(21):5641-5649. doi: 10.1182/bloodadvances.2023012316.
2
The Role of Iron Metabolism in Sepsis-associated Encephalopathy: a Potential Target.铁代谢在脓毒症相关性脑病中的作用：一个潜在的靶点。
Mol Neurobiol. 2024 Jul;61(7):4677-4690. doi: 10.1007/s12035-023-03870-2. Epub 2023 Dec 19.
3
Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects.
地拉罗司和铁-麦芽酚：从发现到药物设计、研发、临床应用及未来前景的四十年。
Int J Mol Sci. 2023 Mar 4;24(5):4970. doi: 10.3390/ijms24054970.
4
Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.地拉罗司：一种具有 40 年历史的多靶点药物，可能对 COVID-19 和具有相似症状的疾病具有活性。
Int J Mol Sci. 2022 Jun 16;23(12):6735. doi: 10.3390/ijms23126735.
5
Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.DBA 患者造血干细胞移植的推荐意见。代表 EBMT 的儿科疾病和重型再生障碍性贫血工作组。
Bone Marrow Transplant. 2021 Dec;56(12):2956-2963. doi: 10.1038/s41409-021-01449-w. Epub 2021 Aug 31.
6
The History of Deferiprone (L1) and the Paradigm of the Complete Treatment of Iron Overload in Thalassaemia.去铁酮（L1）的历史及地中海贫血铁过载完全治疗的范例
Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020011. doi: 10.4084/MJHID.2020.011. eCollection 2020.
7
Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment.钻石黑范贫血的关键问题及新疗法前景
Hematol Oncol Clin North Am. 2018 Aug;32(4):701-712. doi: 10.1016/j.hoc.2018.04.005. Epub 2018 Jun 5.
8
Deferasirox for managing iron overload in people with thalassaemia.地拉罗司用于治疗地中海贫血患者的铁过载。
Cochrane Database Syst Rev. 2017 Aug 15;8(8):CD007476. doi: 10.1002/14651858.CD007476.pub3.
9
Deferiprone-Induced Agranulocytosis : A Critical Review of Five Rechallenged Cases.去铁酮诱导的粒细胞缺乏症：5例再次激发病例的批判性综述。
Clin Drug Investig. 1997 Jun;13(6):345-9. doi: 10.2165/00044011-199713060-00007.
10
Deferiprone-induced agranulocytosis: 20 years of clinical observations.去铁酮诱导的粒细胞缺乏症：20年临床观察
Am J Hematol. 2016 Oct;91(10):1026-31. doi: 10.1002/ajh.24479. Epub 2016 Aug 4.